Cost-Effectiveness of Targeted Prophylaxis among Allogenic Stem Cell Transplant Recipients.
Pharmaceuticals (Basel)
; 16(3)2023 Mar 21.
Article
in En
| MEDLINE
| ID: mdl-36986564
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Health_economic_evaluation
/
Prognostic_studies
Language:
En
Journal:
Pharmaceuticals (Basel)
Year:
2023
Type:
Article
Affiliation country:
Italy